Covid: AstraZeneca, ‘no data increase thrombosis risk in 10 million sample’

London, 12 Mar. (beraking latest news Health) – “An analysis of our safety data (of the vaccine, ed), in more than 10 million cases, found no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any age, gender, batch or country where AstraZeneca vaccine is administered “. This was stated by a company spokesperson after yesterday Denmark, Norway and Iceland suspended the use of the anti-Covid product and other countries, including Italy, blocked the administration of one batch of doses. “The number of these types of events observed is significantly lower in those who are vaccinated than would be expected among the general population,” he added.